ACADIA Pharmaceuticals Inc.
ACAD
$29.18
-$0.21-0.72%
NASDAQ
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 14.88% | -5.61% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 14.88% | -5.61% | |||
| Cost of Revenue | 8.08% | -8.40% | |||
| Gross Profit | 19.04% | -3.82% | |||
| SG&A Expenses | -6.30% | 9.90% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -0.94% | 2.28% | |||
| Operating Income | 919.67% | -126.54% | |||
| Income Before Tax | 1,067.37% | -84.87% | |||
| Income Tax Expenses | 4,252.62% | 100.14% | |||
| Earnings from Continuing Operations | 766.10% | -98.67% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 766.10% | -98.67% | |||
| EBIT | 919.67% | -126.54% | |||
| EBITDA | 2,625.75% | -107.99% | |||
| EPS Basic | 761.97% | -98.68% | |||
| Normalized Basic EPS | 1,059.59% | -84.96% | |||
| EPS Diluted | 800.00% | -98.75% | |||
| Normalized Diluted EPS | 1,066.67% | -85.00% | |||
| Average Basic Shares Outstanding | 0.64% | 0.70% | |||
| Average Diluted Shares Outstanding | 0.08% | 0.79% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||